Skip to main content

Advertisement

SpringerLink
Log in

Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To assess the short-term and long-term efficacy of oral therapy with valganciclovir in patients with Posner-Schlossman Syndrome (PSS).

Methods

This is a retrospective observational study on 11 patients with PSS treated with valganciclovir. The PSS was diagnosed clinically on the basis of recurrent episodes of anterior uveitis associated with attacks of elevated intraocular pressure (IOP). All patients who did not respond to aciclovir, or whose cytomegalovirus (CMV) DNA polymerase chain reaction (PCR) analysis of the aqueous humour was positive, were treated with valganciclovir (Valcyte®). Initially, the drug was given 900 mg twice daily for 3 weeks, followed by 450 mg twice daily for a mean period of 20 months (range 10–46 months).

Results

Eleven patients with mean age of 44 years were included in this study. Four of 11 patients were working in a sanitary profession. Before initiation of valgancicloivir therapy, the highest IOP was 68 mmHg (mean 45 mmHg ±9 mmHg). In the first week of treatment, the IOP decreased significantly (mean 16 mmHg ±10 mmHg) and maintained stability during the entire treatment period. In seven of 11 (63.6 %) patients, valganciclovir led to resolution of inflammatory activity and stable IOP. In six patients, the therapy could be discontinued after a mean of 14 months. However, two patients had a recurrence after discontinuation of valganciclovir treatment. No side effects of therapy were observed.

Conclusions

Long-term oral therapy with valganciclovir seems to lower the recurrence rate in patients with clinically diagnosed PSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Posner A, Schlossman A (1948) Syndrome of unilateral attacks of glaucoma with cyclitic symptoms. Arch Ophthalmol 39:517–535

    Article  CAS  Google Scholar 

  2. de Schryer I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, Davis JL, Bodaghi B (2006) Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 90:852–855

    Article  Google Scholar 

  3. Bloch-Michel E, Dussaix E, Cerqueti P, Patarin D (1987) Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossman syndrome. Int Ophthalmol 11:95–96

    Article  CAS  PubMed  Google Scholar 

  4. Teoh SB, Thean L, Koay E (2005) Cytomegalovirus in etiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction. Eye 19:1338–1340

    Article  PubMed  Google Scholar 

  5. Chee SP, Jap A (2010) Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol 94:1648–1652

    Article  PubMed  Google Scholar 

  6. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standarization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  7. Chee SP, Jap A (2008) Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus positive and negative eyes. Am J Ophthalmol 146:883–889

    Article  PubMed  Google Scholar 

  8. Foster PJ, Ralf B, Quigley HA, Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86:238–242

    Article  PubMed  Google Scholar 

  9. Markomichelakis NN, Canakis N (2002) Cytomegalovirus as a cause of anterior uveitis with sectorial iris atrophy. Ophthalmology 109:879–882

    Article  PubMed  Google Scholar 

  10. Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840

    Article  PubMed  Google Scholar 

  11. Hwang YS, Link KK, Lee JS, Chang SH, Chen KJ, Lai CC, Huang JC, Kuo JH, Hsiao CH (2010) Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch Clin Exp Ophthalmol 248:263–269

    Article  CAS  PubMed  Google Scholar 

  12. Macha A, Mitra AK (2002) Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab Dispos 30:670–675

    Article  CAS  PubMed  Google Scholar 

  13. Morlet N, Young S, Naidoo D, Graham G, Coroneo MT (1996) High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration. Br J Ophthalmol 80:214–216

    Article  CAS  PubMed  Google Scholar 

  14. Castela N, Vermerie N, Chast F, Sauvageon-Martre H, Denis J, Godard V, Goldschmidt P, Pouliquen Y (1994) Ganciclovir ophthalmic gel in herpes simplex virus keratitis: intraocular penetration and efficacy. J Ocul Pharmacol 10:439–451

    Article  CAS  PubMed  Google Scholar 

  15. Kondo K, Kanehima H, Mocarski ES (1994) Human cytomegalovirus latent infection of granulocyte-mycrophage progenitors. Proc Natl Acad Sci U S A 91:11879–11883

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Bruggeman CA (1993) Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol 64:325–333

    Article  CAS  PubMed  Google Scholar 

  17. Hendrix RMG, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50:59–63

    Article  CAS  PubMed  Google Scholar 

  18. Taylor-Wiedeman J, Hayhurst GP, Sissons JG, Sinclair JH (1993) Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 74:265–268

    Article  CAS  PubMed  Google Scholar 

  19. Stanier P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS (1989) Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 299:897–898

    Article  CAS  PubMed  Google Scholar 

  20. Bowden RA (1991) Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus. Transplant Proc 23:136–138

    CAS  PubMed  Google Scholar 

  21. Jap A, Sivakumar M, Chee SP (2001) Is Posner Schlossman syndrome benign? Ophthalmology 108:913–918

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Authors’ contribution

Each author 1) contributed to the conception and design, acquisition of data, analysis and interpretation of data; 2) drafted the article and revised it critically for important intellectual content and final approval of the version to be published.

Conflict of interest

None of the authors has a financial or property interest in any material or method mentioned in this manuscript.

Author information

Authors and Affiliations

  1. Center for Ophthalmology, Eberhard-Karls University Tuebingen, Tuebingen, Germany

    B. Sobolewska, C. Deuter, D. Doycheva & M. Zierhut

  2. Center for Ophthalmology, University Eye Hospital, Eberhard-Karls University, Schleichstr. 12, 72076, Tuebingen, Germany

    B. Sobolewska

Authors
  1. B. Sobolewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Deuter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Doycheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Zierhut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Sobolewska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sobolewska, B., Deuter, C., Doycheva, D. et al. Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol 252, 117–124 (2014). https://doi.org/10.1007/s00417-013-2535-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-013-2535-9

Keywords

Search

Navigation